✦ LIBER ✦

Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study

✍ Scribed by Ani, Ifeanyi; Finelli, Antonio; Alibhai, Shabbir M.H.; Timilshina, Narhari; Fleshner, Neil; Abouassaly, Robert

Book ID: 120030988
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 382 KB
Volume: 111
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410X.2012.11675.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

POSITIVE SURGICAL MARGINS IN PARTIAL NEP

POSITIVE SURGICAL MARGINS IN PARTIAL NEPHRECTOMY DO NOT IMPACT INTERMEDIATE-TERM SURVIVAL: A POPULATION BASED STUDY

✍ Abouassaly, Robert; Alibhai, Shabbir M.H.; Shah, Nasir; Timilshina, Narhari; Fle 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

PD17-11 POSITIVE SURGICAL MARGINS AFTER

PD17-11 POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: PREDICTORS AND IMPACT ON ONCOLOGICAL OUTCOMES

✍ Bansal, Rahul; Kapoor, Anil; Finelli, Antonio; Rendon, Ricardo; Moore, Ron; Brea 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 173 KB

1808 THE IMPACT OF PERI-RENAL FAT ON SUR

1808 THE IMPACT OF PERI-RENAL FAT ON SURGICAL OUTCOMES FOLLOWING PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA

✍ Khemees, Tariq A.; Petros, Firas; Shabsigh, Ahmad; Sharp, David S.; Box, Geoffre 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 121 KB

TREATMENT TRENDS FOR RENAL CELL CARCINOM

TREATMENT TRENDS FOR RENAL CELL CARCINOMA IN A POPULATION-BASED TUMOR REGISTRY: THE POTENTIAL UNDERUSE OF PARTIAL NEPHRECTOMY

✍ Abouassaly, Robert; Finelli, Antonio; Timilshina, Narhari; Alibhai, Shabbir M.H. 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 89 KB

A population-based study evaluating the

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

✍ Daniel Y. C. Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH